Professor Karla Arruda and Professor Marcus Maurer discuss the development and implementation of UCARE in Brazil, and its potential benefits for individuals suffering from chronic spontaneous urticaria (CSU). The conversation extends towards exploring the framework of the Brazilian UCARE centres and projects, and how it can be implemented in other countries. Professor Maurer delves into the clinical efficacy, advantages, and impact on patient quality of life of utilising Bruton’s tyrosine kinase inhibitors for the treatment of CSU, along with further discussion of alternative treatments. Access additional resources by signing up to Medthority and to be notified for future ‘All Things Urticaria’ podcast episodes!
Read more news regarding urticaria
Podcast
November 8, 2023Professor Riccardo Asero joins Professor Marcus Maurer to offer advice on the use of non-steroidal anti-inflammatory drugs (NSAID) in people with chronic spontaneous urticaria (CSU). The experts discuss risk assessment [...]
New centers,News
October 26, 2023A very warm welcome to our 4th UCARE Center in the United States: Miami Itch Ctr Dr. Phillip Frost under Head Gil Yosipovitch. Welcome to the UCARE family, we are [...]
News
October 26, 2023Professor Marcus Maurer is joined by Professor Eduardo Souza Lima to explore the relationship between stress and urticaria, and the implications of mast cells and neuropeptides in chronic spontaneous urticaria. [...]
